More on MMTC
Financials
News
Click line-items for a historical chart and %
| Net loss | -931.23K |
| Depreciation | 46.38K |
| Amortization of costs and fees related to convertible debentures | 89.21K |
| Common stock issued for services | |
| Common stock issued to officers and directors for services | |
| Common stock issued for shares of subsidiary stock | |
| Common stock of subsidiary issued to employees and consultants | |
| Common stock issued as a commission | |
| Common stock issued for accounts payable | |
| Common stock issued to former licensee | |
| Common stock issued/recovered on cancelled agreements | |
| Non-cash compensation for stock options and warrants | |
| Costs and fees related to issuance of convertible debt | |
| Interest expense related to beneficial conversion feature | |
| Interest paid with common stock | |
| Interest on notes receivable for common stock | |
| Prepaid expenses | -3.39K |
| Inventories | 0 |
| Notes receivable | |
| Trade accounts payable | 57.34K |
| Accounts payable to officers and directors | 109.13K |
| Accrued payroll and other expenses | 166.13K |
| Net cash used in operating activities | |
| Purchase of fixed assets | -9.86K |
| Net cash used in investing activities | |
| Principal payments on notes payable to stockholders | 0 |
| Proceeds from issuance of notes payable to a related party | 96.72K |
| Proceeds from issuance of notes and convertible notes payable | |
| Proceeds from issuance of common stock, net | 127K |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash at beginning of period | |
| Cash at end of period | |
| Interest paid | 36.95K |
| Income taxes paid | |
| Beneficial conversion feature of convertible debentures | 0 |
| Common stock issued in consideration for loans | |
| Conversion of convertible notes payable to shares of common stock | |
Entities mentioned with MMTC
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Dividend | View Related Stories »
- Show More...
